Digpatho S.A.S.
DigPatho offers AI-powered pathology tools that transform cancer diagnosis by analyzing microscopic images to identify and label cellular components. The platform uses deep learning and machine learning to support pathologists in faster, more accurate diagnoses, with biomarker tools for breast cancer (Ki67, HER2, ER/PR) and other analyses. It is a B2B SaaS product designed for pathology labs, hospitals, and research institutions, with seamless IT integration, transparency in AI model development, and strong security. The technology stack includes AI, deep learning, and machine learning algorithms applied to medical imaging. The company targets global expansion, aiming to improve diagnostic accuracy, efficiency, and patient care across healthcare systems.
Digpatho S.A.S.
DigPatho offers AI-powered pathology tools that transform cancer diagnosis by analyzing microscopic images to identify and label cellular components. The platform uses deep learning and machine learning to support pathologists in faster, more accurate diagnoses, with biomarker tools for breast cancer (Ki67, HER2, ER/PR) and other analyses. It is a B2B SaaS product designed for pathology labs, hospitals, and research institutions, with seamless IT integration, transparency in AI model development, and strong security. The technology stack includes AI, deep learning, and machine learning algorithms applied to medical imaging. The company targets global expansion, aiming to improve diagnostic accuracy, efficiency, and patient care across healthcare systems.